| 000 | 01929 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517204124.0 | ||
| 264 | 0 | _c20190729 | |
| 008 | 201907s 0 0 eng d | ||
| 022 | _a1527-7755 | ||
| 024 | 7 |
_a10.1200/JCO.2017.75.3335 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMorgans, Alicia K | |
| 245 | 0 | 0 |
_aQuality of Life During Treatment With Chemohormonal Therapy: Analysis of E3805 Chemohormonal Androgen Ablation Randomized Trial in Prostate Cancer. _h[electronic resource] |
| 260 |
_bJournal of clinical oncology : official journal of the American Society of Clinical Oncology _c04 2018 |
||
| 300 |
_a1088-1095 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdenocarcinoma _xdrug therapy |
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadministration & dosage |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aDocetaxel _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPain Measurement |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 | _aSurveys and Questionnaires |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aChen, Yu-Hui | |
| 700 | 1 | _aSweeney, Christopher J | |
| 700 | 1 | _aJarrard, David F | |
| 700 | 1 | _aPlimack, Elizabeth R | |
| 700 | 1 | _aGartrell, Benjamin A | |
| 700 | 1 | _aCarducci, Michael A | |
| 700 | 1 | _aHussain, Maha | |
| 700 | 1 | _aGarcia, Jorge A | |
| 700 | 1 | _aCella, David | |
| 700 | 1 | _aDiPaola, Robert S | |
| 700 | 1 | _aPatrick-Miller, Linda J | |
| 773 | 0 |
_tJournal of clinical oncology : official journal of the American Society of Clinical Oncology _gvol. 36 _gno. 11 _gp. 1088-1095 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1200/JCO.2017.75.3335 _zAvailable from publisher's website |
| 999 |
_c28162547 _d28162547 |
||